Securian Asset Management Inc. Has $1.05 Million Stock Holdings in Agilent Technologies, Inc. $A

Securian Asset Management Inc. decreased its position in Agilent Technologies, Inc. (NYSE:A) by 43.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,708 shares of the medical research company’s stock after selling 5,975 shares during the quarter. Securian Asset Management Inc.’s holdings in Agilent Technologies were worth $1,049,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Board of the Pension Protection Fund acquired a new position in Agilent Technologies in the 4th quarter valued at $27,000. Physician Wealth Advisors Inc. lifted its position in Agilent Technologies by 490.0% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after acquiring an additional 196 shares during the last quarter. Torren Management LLC acquired a new position in Agilent Technologies during the 4th quarter worth $32,000. State of Wyoming bought a new stake in Agilent Technologies during the second quarter valued at about $35,000. Finally, Johnson Financial Group Inc. bought a new stake in Agilent Technologies during the third quarter valued at about $49,000.

Wall Street Analyst Weigh In

A has been the topic of a number of recent analyst reports. UBS Group dropped their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Barclays lowered their target price on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. HSBC assumed coverage on Agilent Technologies in a research report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price target on the stock. Wells Fargo & Company reduced their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research report on Thursday, February 26th. Finally, TD Cowen lowered their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Two analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $163.71.

Agilent Technologies Trading Up 1.3%

Shares of A stock opened at $112.93 on Wednesday. Agilent Technologies, Inc. has a 52-week low of $107.07 and a 52-week high of $160.27. The stock has a market cap of $31.91 billion, a price-to-earnings ratio of 24.93, a P/E/G ratio of 2.35 and a beta of 1.22. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The firm has a fifty day moving average of $115.46 and a 200-day moving average of $131.30.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). The business had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. Agilent Technologies’s revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 5.95 earnings per share for the current fiscal year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.